Skip to main content
. 2016 Sep 8;159(3):553–563. doi: 10.1007/s10549-016-3973-y

Fig. 4.

Fig. 4

Cumulative incidence of cIBC by treatment strategy compared with the expected cumulative incidence of IBC in the general population (dashed line) for a women <50 years, and b women ≥50 years, with death as competing risk. BCS breast-conserving surgery, RT radiotherapy. P values based on competing risk regression, adjusted for age (continuous) [30]